BLOK:LSE:LSE-First Trust Indxx Innovative Transaction & Process UCITS ETF (GBX)

ETF | Others |

Last Closing

USD 3126.75

Change

0.00 (0.00)%

Market Cap

N/A

Volume

346.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-02 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XNIF:LSE Xtrackers Nifty 50 Swap UCITS ..

N/A

USD 292,109.69B
XNID:LSE Xtrackers Nifty 50 Swap UCITS ..

N/A

USD 292,109.69B
0R1O:LSE Amazon.com Inc.

N/A

USD 1,607.29B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

N/A

USD 701.81B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

N/A

USD 636.56B
0R1I:LSE NVIDIA Corp.

N/A

USD 618.20B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

N/A

USD 266.08B
PRJU:LSE Amundi Index Solutions - Amund..

N/A

USD 260.39B
0QZO:LSE 0QZO

N/A

USD 258.54B

ETFs Containing BLOK:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 5.14% 77% C+ 69% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.14% 77% C+ 69% C-
Trailing 12 Months  
Capital Gain 19.46% 88% B+ 80% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 19.46% 87% B+ 79% B-
Trailing 5 Years  
Capital Gain 82.48% 82% B 85% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 82.48% 80% B- 84% B
Average Annual (5 Year Horizon)  
Capital Gain 12.63% 70% C- 72% C
Dividend Return 12.63% 69% C- 71% C-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 13.34% 54% F 71% C-
Risk Adjusted Return 94.72% 85% B 91% A-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike